HemoRea: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
HemoRea
Largest movements
- Receivables within one year -€24,000
no longer reported in 2025 (was €24,000)
- Cash +€13,869
up €13,869 (+40.5%), from €34,264 to €48,132
mainly Net result for the year (+€39,687) and Receivables within one year (+€24,000)
- Trade debts -€24,162
down €24,162 (-94.1%), from €25,675 to €1,513
- Other debts +€16,002
up €16,002 (+70.6%), from €22,656 to €38,658
- Tax, wage and social debts -€1,995
down €1,995 (-20.6%), from €9,703 to €7,708
- Gross operating margin +€19,884
up €19,884 (+56.8%), from €34,992 to €54,875
- Taxes +€5,138
up €5,138 (+56.4%), from €9,117 to €14,255
- Financial charges -€554
down €554 (-86.3%), from €642 to €88
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €60,703 | €50,378 | -€10,326 | -17.0% |
| Fixed assets | 21/28 | €2,440 | €1,946 | -€494 | -20.2% |
| Tangible fixed assets | 22/27 | €2,440 | €1,946 | -€494 | -20.2% |
| Plant, machinery and equipment | 23 | €2,440 | €1,946 | -€494 | -20.2% |
| Current assets | 29/58 | €58,264 | €48,432 | -€9,832 | -16.9% |
| Amounts receivable within one year | 40/41 | €24,000 | - | -€24,000 | |
| Trade receivables | 40 | €24,000 | - | -€24,000 | |
| Cash at bank and in hand | 54/58 | €34,264 | €48,132 | +€13,869 | +40.5% |
| Deferred charges and accrued income | 490/1 | - | €299 | +€299 | |
| Total equity and liabilities | 10/49 | €60,703 | €50,378 | -€10,326 | -17.0% |
| Equity | 10/15 | €2,500 | €2,500 | = | 0.0% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Amounts payable | 17/49 | €58,203 | €47,878 | -€10,326 | -17.7% |
| Amounts payable within one year | 42/48 | €58,033 | €47,878 | -€10,156 | -17.5% |
| Trade debts | 44 | €25,675 | €1,513 | -€24,162 | -94.1% |
| Suppliers | 440/4 | €25,675 | €1,513 | -€24,162 | -94.1% |
| Taxes, remuneration and social security | 45 | €9,703 | €7,708 | -€1,995 | -20.6% |
| Taxes | 450/3 | €9,703 | €7,708 | -€1,995 | -20.6% |
| Other amounts payable | 47/48 | €22,656 | €38,658 | +€16,002 | +70.6% |
| Accrued charges and deferred income | 492/3 | €170 | - | -€170 | |
| Non-recurring operating income | 76A | €10,325 | - | -€10,325 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €28 | €494 | +€465 | +1642.9% |
| Other operating charges | 640/8 | €673 | €352 | -€321 | -47.6% |
| Gross operating margin | 9900 | €34,992 | €54,875 | +€19,884 | +56.8% |
| Operating profit (loss) | 9901 | €34,291 | €54,030 | +€19,739 | +57.6% |
| Financial charges | 65/66B | €642 | €88 | -€554 | -86.3% |
| Recurring financial charges | 65 | €642 | €88 | -€554 | -86.3% |
| Profit (loss) for the period before taxes | 9903 | €33,648 | €53,942 | +€20,293 | +60.3% |
| Income taxes | 67/77 | €9,117 | €14,255 | +€5,138 | +56.4% |
| Profit (loss) for the period | 9904 | €24,531 | €39,687 | +€15,156 | +61.8% |
| Profit (loss) for the period to be appropriated | 9905 | €24,531 | €39,687 | +€15,156 | +61.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.